Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D Rankin

Showing results (131-140 of 356) with videos related to

Pageof 36
Sort By:
Journal of the American Academy of Dermatology|February 15, 2025
Response to Potestio et al., "Comment on Real-world experience of bimekizumab for plaque psoriasis in adult patients with prior exposure to interleukin-17 inhibitors: A 16-week multicenter retrospective review"Siddhartha Sood, Alexander Rimke, Brian D Rankin, et al.
Journal of the American Academy of Dermatology|April 22, 2024
Real-world experience of bimekizumab for adult patients with plaque psoriasis: A 16-week multicenter retrospective studyAlexander Rimke, Siddhartha Sood, Brian D Rankin, et al.
Pilot and Feasibility Studies|December 21, 2024
The collaborative working group method for pre-trial knowledge mobilisation: a qualitative evaluation of a structured process for iteratively refining a complex intervention (DAFNEplus)J P Breckenridge, R Gossage-Worrall, P Chadwick, et al.
Diabetic Medicine : a Journal of the British Diabetic Association|January 29, 2020
Health professionals' views about who would benefit from using a closed-loop system: a qualitative studyJ Lawton, B Kimbell, D Rankin, et al.
Journal of Cutaneous Medicine and Surgery|June 5, 2026
Real-World Effectiveness and Safety of Deucravacitinib for Adult Patients with Plaque Psoriasis: A 16-Week Multicenter Retrospective Study of Monotherapy and Combination TherapySiddhartha Sood, Ahmed Bagit, Khalad Maliyar, et al.
The Journal of Dermatological Treatment|April 21, 2022
Incidence and prognosis of COVID-19 in patients with atopic diseases on dupilumab: a multicentre retrospective cohort studyBrian D Rankin, Jorge-Ryan Georgakopoulos, Muskaan Sachdeva, et al.
Dermatitis : Contact, Atopic, Occupational, Drug|October 24, 2024
Effectiveness and Safety of Upadacitinib in Adolescent and Adult Patients with Atopic Dermatitis: An Analysis of Long-Term (Week 52) Data from a Real-World Multicenter Retrospective ReviewBrian D Rankin, Siddhartha Sood, Ye-Jean Park, et al.
Journal of the American Academy of Dermatology|June 17, 2024
Real-world experience of bimekizumab for adult patients with plaque psoriasis: A 52-week multicenter retrospective studySiddhartha Sood, Alexander Rimke, Brian D Rankin, et al.
Mbio|May 9, 2022
Serine Protease Inhibitors Restrict Host Susceptibility to SARS-CoV-2 InfectionsEbba Rosendal, Ionut Sebastian Mihai, Miriam Becker, et al.
Journal of Cutaneous Medicine and Surgery|September 3, 2024
Real-World Effectiveness and Safety of Risankizumab in Adult Patients with Plaque Psoriasis: A 16-Week International Multicenter Retrospective Cohort StudyAhmed Bagit, Khalad Maliyar, Mark Mansour, et al.
Pageof 36

Showing results (131-140 of 356) with videos related to

Sort By:
Pageof 36
Journal of the American Academy of Dermatology|February 15, 2025
Response to Potestio et al., "Comment on Real-world experience of bimekizumab for plaque psoriasis in adult patients with prior exposure to interleukin-17 inhibitors: A 16-week multicenter retrospective review"Siddhartha Sood, Alexander Rimke, Brian D Rankin, et al.
Journal of the American Academy of Dermatology|April 22, 2024
Real-world experience of bimekizumab for adult patients with plaque psoriasis: A 16-week multicenter retrospective studyAlexander Rimke, Siddhartha Sood, Brian D Rankin, et al.
Pilot and Feasibility Studies|December 21, 2024
The collaborative working group method for pre-trial knowledge mobilisation: a qualitative evaluation of a structured process for iteratively refining a complex intervention (DAFNEplus)J P Breckenridge, R Gossage-Worrall, P Chadwick, et al.
Diabetic Medicine : a Journal of the British Diabetic Association|January 29, 2020
Health professionals' views about who would benefit from using a closed-loop system: a qualitative studyJ Lawton, B Kimbell, D Rankin, et al.
Journal of Cutaneous Medicine and Surgery|June 5, 2026
Real-World Effectiveness and Safety of Deucravacitinib for Adult Patients with Plaque Psoriasis: A 16-Week Multicenter Retrospective Study of Monotherapy and Combination TherapySiddhartha Sood, Ahmed Bagit, Khalad Maliyar, et al.
The Journal of Dermatological Treatment|April 21, 2022
Incidence and prognosis of COVID-19 in patients with atopic diseases on dupilumab: a multicentre retrospective cohort studyBrian D Rankin, Jorge-Ryan Georgakopoulos, Muskaan Sachdeva, et al.
Dermatitis : Contact, Atopic, Occupational, Drug|October 24, 2024
Effectiveness and Safety of Upadacitinib in Adolescent and Adult Patients with Atopic Dermatitis: An Analysis of Long-Term (Week 52) Data from a Real-World Multicenter Retrospective ReviewBrian D Rankin, Siddhartha Sood, Ye-Jean Park, et al.
Journal of the American Academy of Dermatology|June 17, 2024
Real-world experience of bimekizumab for adult patients with plaque psoriasis: A 52-week multicenter retrospective studySiddhartha Sood, Alexander Rimke, Brian D Rankin, et al.
Mbio|May 9, 2022
Serine Protease Inhibitors Restrict Host Susceptibility to SARS-CoV-2 InfectionsEbba Rosendal, Ionut Sebastian Mihai, Miriam Becker, et al.
Journal of Cutaneous Medicine and Surgery|September 3, 2024
Real-World Effectiveness and Safety of Risankizumab in Adult Patients with Plaque Psoriasis: A 16-Week International Multicenter Retrospective Cohort StudyAhmed Bagit, Khalad Maliyar, Mark Mansour, et al.
Pageof 36